{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:49:56Z","timestamp":1791341396502,"version":"4.3.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/aci.0b013e3283511396","type":"journal-article","created":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T04:31:11Z","timestamp":1328243471000},"page":"102-110","source":"Crossref","is-referenced-by-count":20,"title":["The role of lymphocyte proliferation tests in assessing occupational sensitization and disease"],"prefix":"10.1097","volume":"12","author":[{"given":"Stella E.","family":"Hines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/ACI.0b013e3282f824a4","article-title":"Immunology of chronic beryllium disease.","volume":"8","author":"Samuel","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-483X(02)00439-0","article-title":"Identification of an abnormal beryllium lymphocyte proliferation test.","volume":"183","author":"Frome","year":"2003","journal-title":"Toxicology"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2008.08625.x","article-title":"Skin sensitization: strategies for the assessment and management of risk.","volume":"159","author":"Basketter","year":"2008","journal-title":"Br J Dermatol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/toxsci\/kfq054","article-title":"Irritancy and allergic responses induced by topical application of ortho-phthalaldehyde.","volume":"115","author":"Anderson","year":"2010","journal-title":"Toxicol Sci"},{"key":"R7-3-20210128","first-page":"14006","article-title":"The murine local lymph node assay: a test method for assessing the allergic contact dermatitis potential of chemicalscompounds.","volume":"64","year":"1999","journal-title":"Fed Regist"},{"key":"R9-3-20210128","first-page":"267","article-title":"Beryllium disease screening in the ceramics industry: blood lymphocyte test performance and exposure-disease relations.","volume":"35","author":"Kreiss","year":"1993","journal-title":"J Occup Med"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.","volume":"88","author":"Mroz","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00043764-198907000-00011","article-title":"Screening blood test identifies subclinical beryllium disease.","volume":"31","author":"Kreiss","year":"1989","journal-title":"J Occup Med"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/00043764-199111000-00020","article-title":"Blood testing for chronic beryllium disease.","volume":"33","author":"Kreiss","year":"1991","journal-title":"J Occup Med"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajim.20082","article-title":"The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance.","volume":"46","author":"Stange","year":"2004","journal-title":"Am J Ind Med"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajim.20548","article-title":"Optimizing BeLPT criteria for beryllium sensitization.","volume":"51","author":"Middleton","year":"2008","journal-title":"Am J Ind Med"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajim.20241","article-title":"The BeLPT: algorithms and implications.","volume":"49","author":"Middleton","year":"2006","journal-title":"Am J Ind Med"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajim.20909","article-title":"Interpreting borderline BeLPT results.","volume":"54","author":"Middleton","year":"2011","journal-title":"Am J Ind Med"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.","volume":"171","author":"Newman","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ajim.20736","article-title":"Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.","volume":"52","author":"Mroz","year":"2009","journal-title":"Am J Ind Med"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2458-10-5","article-title":"Long-term follow-up of beryllium sensitized workers from a single employer.","volume":"10","author":"Duggal","year":"2010","journal-title":"BMC Public Health"},{"issue":"Suppl 1","key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/00333549091244S113","article-title":"Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.","volume":"124","author":"Thomas","year":"2009","journal-title":"Public Health Rep"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1289\/ehp.0800455","article-title":"A reconsideration of acute beryllium disease.","volume":"117","author":"Cummings","year":"2009","journal-title":"Environ Health Perspect"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JOM.0b013e3181d6c338","article-title":"Evaluation of a preventive program to reduce sensitization at a beryllium metal, oxide, and alloy production plant.","volume":"52","author":"Bailey","year":"2010","journal-title":"J Occup Environ Med"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajim.20913","article-title":"Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.","volume":"54","author":"Mikulski","year":"2011","journal-title":"Am J Ind Med"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/JOM.0b013e31820a408a","article-title":"Prevalence of beryllium sensitization among Department of Defense conventional munitions workers at low risk for exposure.","volume":"53","author":"Mikulski","year":"2011","journal-title":"J Occup Environ Med"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/ajim.20816","article-title":"Beryllium sensitivity among workers at a Norwegian aluminum smelter.","volume":"53","author":"Nilsen","year":"2010","journal-title":"Am J Ind Med"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/JOM.0b013e3181e36439","article-title":"Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.","volume":"52","author":"Arjomandi","year":"2010","journal-title":"J Occup Environ Med"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","article-title":"Interaction of genetic and exposure factors in the prevalence of berylliosis.","volume":"32","author":"Richeldi","year":"1997","journal-title":"Am J Ind Med"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1183\/09031936.01.00106201","article-title":"Major histocompatibility locus genetic markers of beryllium sensitization and disease.","volume":"18","author":"Saltini","year":"2001","journal-title":"Eur Respir J"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0300-483X(01)00410-3","article-title":"Beryllium sensitivity is linked to HLA-DP genotype.","volume":"165","author":"Wang","year":"2001","journal-title":"Toxicology"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity.","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease.","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajim.20045","article-title":"The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.","volume":"46","author":"McCanlies","year":"2004","journal-title":"Am J Ind Med"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1098\/rsif.2007.1223","article-title":"Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease.","volume":"5","author":"Snyder","year":"2008","journal-title":"J R Soc Interface"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00109-004-0626-0","article-title":"Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.","volume":"83","author":"Gaede","year":"2005","journal-title":"J Mol Med (Berl)"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1289\/ehp.6327","article-title":"Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.","volume":"111","author":"Snyder","year":"2003","journal-title":"Environ Health Perspect"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1164\/rccm.201002-0254OC","article-title":"Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.","volume":"183","author":"Van Dyke","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1165\/rcmb.2009-0150OC","article-title":"Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.","volume":"43","author":"Dobis","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/oem.2009.050039","article-title":"Noninvasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.","volume":"67","author":"Fireman","year":"2010","journal-title":"Occup Environ Med"},{"key":"R41-3-20210128","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2011.08.022","article-title":"Beryllium-specific CD4() T cells in blood as a biomarker of disease progression.","volume":"128","author":"Martin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R42-3-20210128","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2230.2008.02725.x","article-title":"Lymphocyte proliferation testing in chromium allergic contact dermatitis.","volume":"33","author":"Martins","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1365-2222.2008.02970.x","article-title":"Detection of chromium allergy by cellular in vitro methods.","volume":"38","author":"Lindemann","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0536.2011.01886.x","article-title":"Metal sensitivity in patients with orthopaedic implants: a prospective study.","volume":"64","author":"Frigerio","year":"2011","journal-title":"Contact Dermatitis"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jor.21015","article-title":"Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty.","volume":"28","author":"Kwon","year":"2010","journal-title":"J Orthop Res"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1098\/rsif.2008.0142","article-title":"The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.","volume":"5","author":"Revell","year":"2008","journal-title":"J R Soc Interface"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0536.2010.01744.x","article-title":"Nickel (Ni) allergic patients with complications to Ni containing joint replacement show preferential IL-17 type reactivity to Ni.","volume":"63","author":"Summer","year":"2010","journal-title":"Contact Dermatitis"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0022-3913(08)60233-4","article-title":"Suspected association of an allergic reaction with titanium dental implants: a clinical report.","volume":"100","author":"Egusa","year":"2008","journal-title":"J Prosthet Dent"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2176\/nmc.50.608","article-title":"Allergic reaction following arachnoid plasty with a fibrin sealant.","volume":"50","author":"Kanazawa","year":"2010","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0536.2010.01835.x","article-title":"Contact allergy to beryllium chloride: report of 12 cases.","volume":"64","author":"Toledo","year":"2011","journal-title":"Contact Dermatitis"},{"key":"R52-3-20210128","first-page":"743","article-title":"Epoxy resins.","volume":"14","author":"Bray","year":"1999","journal-title":"Occup Med"},{"key":"R53-3-20210128","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1398-9995.2004.00511.x","article-title":"Exposure to methyl methacrylate and hypersensitivity pneumonitis in dental technicians.","volume":"59","author":"Scherpereel","year":"2004","journal-title":"Allergy"},{"key":"R54-3-20210128","first-page":"A1179","article-title":"Respiratory symptoms, spirometry and immunologic sensitivity in epoxy resin workers.","volume":"183","author":"Hines","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15476910802604291","article-title":"Evaluation of irritancy and sensitization potential of metalworking fluid mixtures and components.","volume":"6","author":"Anderson","year":"2009","journal-title":"J Immunotoxicol"},{"key":"R56-3-20210128","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jaci.2004.04.031","article-title":"Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (ortho-phthalaldehyde) high-level disinfectant in 4 patients after cytoscopy.","volume":"114","author":"Sokol","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R57-3-20210128","first-page":"751052","article-title":"Inhalation of ortho-phthalaldehyde vapor causes respiratory sensitization in mice.","volume":"2011","author":"Johnson","year":"2011","journal-title":"J Allergy (Cairo)"},{"key":"R59-3-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/3-540-48664-X_4","article-title":"Benzotrifluoride and derivatives: useful solvents for organic synthesis and fluorous synthesis.","volume":"206","author":"Maul","year":"1999","journal-title":"Top Curr Chem"},{"key":"R60-3-20210128","first-page":"238513","article-title":"Allergic potential and immunotoxicity induced by topical application of 1-chloro-4-(trifluoromethyl)benzene (PCBTF) in a murine model.","volume":"2011","author":"Franko","year":"2011","journal-title":"J Allergy (Cairo)"},{"key":"R61-3-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cyto.b.20015","article-title":"Flow cytometric test for beryllium sensitivity.","volume":"60","author":"Milovanova","year":"2004","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e3283511396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:35:36Z","timestamp":1786048536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-201204000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e3283511396","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}